(traduction) « Par rapport à tous les autres vaccins, le Gardasil seul est associé à plus de > 60% de tous les (EIG) (= effets indésirables graves)
(y compris 63,8% de tous les décès et 81,2% des cas d’invalidité
permanente) chez les femmes de moins de 30 ans. Dans le contexte, alors
que les femmes de ce groupe d’âge ont un risque presque nul de mourir du
cancer du col utérin, elles sont confrontées à un risque de mourir et à
un état d’invalidité permanente par un vaccin qui n’a pas empêché un
seul cas de cancer du col de l’utérus jusqu’à présent. »
TABLE 1— Age-Adjusted
Rate of Adverse Reactions (ADRs) Related to Gardasil Compared With All
Other Vaccines in the United States Reported to the Vaccine Adverse
Event Reporting System (VAERS) as of March 25, 2012.
----------------------------------------------------------------------------------------------
Events -------------------Gardasil, No. All Vaccines, No. Gardasil ADRs, %
----------------------------------------------------------------------------------------------
All -----------------------------14 616 -----------31 713 -------------46.1
Serious -----------------------1 272 -------------2 077 ------------61.2
Deaths ---------------------------- 37 -----------------58 -------------63.8
Life-threatening ---------------- 289 --------------444 -------------65.1
Permanently disabled -------468 ---------------572 -------------81.2
Prolonged hospitalization -172 ---------------229 --------------75.1
Emergency room visit ------6892 ------------12 927 -------------53.3
Compared with all other
vaccines, Gardasil alone is associated with > 60% of all serious ADRs
(including 63.8% of all deaths and 81.2% cases of permanent disability)
in females younger than 30 years. In context, while females in
this age group have a near-zero risk of dying from cervical cancer, they
are faced with a risk of dying and a permanently disabling condition
from a vaccine that has not prevented a single case of cervical cancer
thus far. For a vaccine with uncertain benefits designed to prevent a
disease that is preventable through Papanicolaou screening combined
with the loop electrosurgical excision procedure, which together carry
no such risks, the potential for harm to those vaccinated should be
negligible.
Note. The VAERS Internet database (http://wonder.cdc.gov/vaers.html)
was searched using the following criteria : (1) gender (female) ; (2)
age (16–29 y [target group for HPV vaccines]) ; and (3) date range
(2006-2012 [Gardasil postlicensure period]).
Source : Who Profits From Uncritical Acceptance of Biased Estimates of Vaccine Efficacy and Safety ?
Lucija Tomljenovic, PhD and Christopher A. Shaw, PhD, 2012 September